Chembio Diagnostics, Inc. (CEMI) SEC filings
CEMI SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CEMI overview →
No CEMI SEC filing events in the measured window.
Nothing matched in the current window — the CEMI overview has every event we measure for this name.
Get an email when CEMI moves on news →Keep exploring
More CEMI: earnings → · analyst actions → · CEMI overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| GW PHARMACEUTICALS PLC AMERICA (GWPH) | 942 | -0.06% | 47% |
| Intersect ENT, Inc. (XENT) | 937 | 0.00% | 48% |
| PROGENICS PHARMACEUTICALS (PGNX) | 935 | -0.17% | 42% |
| ZIOPHARM Oncology Inc (ZIOP) | 932 | -0.42% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.